Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia… (Abstract)
Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis Biomedicines As revised 23 March 2023 https://www.mdpi.com/2227-9059/11/4/1087 Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that […]
JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians (news)
JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians 22 February 2023 https://www.biospace.com/article/releases/janone-to-present-important-trial-results-at-annual-meeting-of-american-society-of-interventional-pain-physicians/ JAN 123’s in vitro study on low dose naltrexone vies for the Society’s “Best Research Abstract of the Year”. JanOne, a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of […]
Low-Dose Naltrexone Offers New Hope for Pain Sufferers (News)
Low-Dose Naltrexone Offers New Hope for Pain Sufferers Psychology Today 25 April 2022 https://www.psychologytoday.com/us/blog/full-catastrophe-parenting/202204/low-dose-naltrexone-offers-new-hope-pain-sufferers Key points: ~ Persistent pain can have an adverse impact on mood, relationships, job performance, and overall quality of life. ~ New ways of treating pain are needed that can be worthy alternatives to prolonged opiate use. ~ In low doses, […]
Neuropathic Pain and Low Dose Naltrexone (LDN)
Low-dose Naltrexone for atopic dermatitis? (News)
Low-dose Naltrexone for atopic dermatitis? National Eczema Association 11 April 2019 https://nationaleczema.org/naltrexone/ Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disorders, affecting up to 20 percent of children and 10 percent of adults. The main goals of treatment are to decrease itching and pain, dampen the skin inflammation, repair the skin […]
Drug relieves chronic pain without the addiction risk (News)
Drug relieves chronic pain without the addiction risk Futurity 17 February 2021 https://www.futurity.org/naltrexone-chronic-pain-addiction-opioids-2519592/ A low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, researchers report.
Comments on “Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review” (Abstract)
Comments on “Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review” Pain Physician December 2021 https://www.painphysicianjournal.com/current/pdf?article=NzM4NA%3D%3D The authors allege the authors should use chronic pain syndrome in the title instead of chronic regional pain syndrome, as its methodology is based on the use of low dose naltrexone for varied chronic […]
In Response Comments on “Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review” (Abstract)
In Response Comments on “Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review” Pain Physician December 2021 https://www.painphysicianjournal.com/current/pdf?article=NzM4NQ%3D%3D The authors of “Low-Dose Naltrexone Use for Patients With Chronic Regional Pain Syndrome,” conducted a systematic literature review to determine the effects of low-dose naltrexone (LDN) in the treatment of chronic pain […]
FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) (News)
FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) (News) Cision PR Newswire 09 September 2021 https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-status-to-soin-therapeutics-for-low-dose-naltrexone-ldn-to-treat-complex-regional-pain-syndrome-crps-301372111.html Soin Therapeutics, a pharmaceutical company based in Dayton, OH, was granted orphan drug status from the FDA for low dose naltrexone (LDN) to treat complex regional pain […]
Dr Richard Nahas, LDN Radio Show 2014 (LDN, low dose naltrexone)
Dr Richard Nahas, LDN Radio Show 2014 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health. Dr Nahas practices in Ottawa, Canada at the Seekers Centre. He was an ER doctor for 5 years and in […]